TBRGMay 28, 2026 at 10:09 PM UTCHealth Care Equipment & Services

TruBridge Faces Securities Investigation Amid Stretched Fundamentals

Read source article

What happened

TruBridge is under investigation by Rosen Law Firm for potentially issuing materially misleading business information, adding legal risk to an already challenged financial picture. The company's latest filings show 94% recurring revenue and a 19% Adjusted EBITDA margin, but net debt/EBITDA stands at 4.65x, bookings declined year-over-year, and internal control weaknesses persist. The stock trades at roughly 13x EV/EBITDA, well above a DCF anchor of $4.47 per share, leaving scant margin for error. This investigation could distract management, increase legal costs, and further pressure an already stretched balance sheet.

Implication

If the investigation finds no wrongdoing, the core RCM story remains intact but deleveraging and control remediation are needed for re-rating. If material misstatements are uncovered, equity could be severely impaired; wait for resolution before considering a position.

Thesis delta

The securities investigation introduces a new binary risk that amplifies existing concerns around leverage, controls, and valuation. The thesis now hinges not just on operational execution but also on legal outcomes; the risk/reward has tilted decisively negative near-term.

Confidence

MEDIUM